The DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives
Open accessAbstract
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. NAFLD begins as a relatively benign hepatic steatosis which can evolve to non-alcoholic steatohepatitis (NASH); the risk of cirrhosis and hepatocellular carcinoma (HCC) increases when fibrosis is present. NAFLD represents a complex process implicating numerous factors—genetic, metabolic, and dietary—intertwined in a multi-hit etiopathogenetic model. Recent data have highlighted the role of gut dysbiosis, which may render the bowel more permeable, leading to increased free fatty acid absorption, bacterial migration, and a parallel release of toxic bacterial products, lipopolysaccharide (LPS), and proinflammatory cytokines that initiate and sustain inflammation. Although gut dysbiosis is present in each disease stage, there is currently no single microbial signature to distinguish or predict which patients will evolve from NAFLD to NASH and HCC. Using 16S rRNA sequencing, the majority of patients with NAFLD/NASH exhibit increased numbers of Bacteroidetes and differences in the presence of Firmicutes, resulting in a decreased F/B ratio in most studies. They also present an increased proportion of species belonging to Clostridium, Anaerobacter, Streptococcus, Escherichia, and Lactobacillus, whereas Oscillibacter, Flavonifaractor, Odoribacter, and Alistipes spp. are less prominent. In comparison to healthy controls, patients with NASH show a higher abundance of Proteobacteria, Enterobacteriaceae, and Escherichia spp., while Faecalibacterium prausnitzii and Akkermansia muciniphila are diminished. Children with NAFLD/NASH have a decreased proportion of Oscillospira spp. accompanied by an elevated proportion of Dorea, Blautia, Prevotella copri, and Ruminococcus spp. Gut microbiota composition may vary between population groups and different stages of NAFLD, making any conclusive or causative claims about gut microbiota profiles in NAFLD patients challenging. Moreover, various metabolites may be involved in the pathogenesis of NAFLD, such as short-chain fatty acids, lipopolysaccharide, bile acids, choline and trimethylamine-N-oxide, and ammonia. In this review, we summarize the role of the gut microbiome and metabolites in NAFLD pathogenesis, and we discuss potential preventive and therapeutic interventions related to the gut microbiome, such as the administration of probiotics, prebiotics, synbiotics, antibiotics, and bacteriophages, as well as the contribution of bariatric surgery and fecal microbiota transplantation in the therapeutic armamentarium against NAFLD. Larger and longer-term prospective studies, including well-defined cohorts as well as a multi-omics approach, are required to better identify the associations between the gut microbiome, microbial metabolites, and NAFLD occurrence and progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Villanueva, A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1713263 · Cited by 4,508
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Autophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Turnbaugh, P. J., Bäckhed, F., Fulton, L., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.02.015 · Cited by 2,915
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F. M. (2012) · Diabetes · doi:10.2337/db11-1019 · Cited by 2,404
Butyrate improves insulin sensitivity and increases energy expenditure in mice
Gao, Z., Yin, J., Zhang, J., Ward, R. E., Martin, R. J., Lefevre, M., Cefalu, W. T., & Ye, J. (2009) · Diabetes · doi:10.2337/db08-1637 · Cited by 2,204 · cited 1×
“SCFAs are transferred to the liver by means of the portal circulation, thereby serving as precursors for gluconeogenesis and lipogenesis [68,69].”
BackgroundPlovier, H., Everard, A., Druart, C., Depommier, C., Van Hul, M., Geurts, L., Chilloux, J., Ottman, N., Duparc, T., Lichtenstein, L., et al. (2017) · Nature Medicine · doi:10.1038/nm.4236 · Cited by 2,204
Alterations of the human gut microbiome in liver cirrhosis
Qin, N., Yang, F., Li, A., Prifti, E., Chen, Y., Shao, L., Guo, J., Le Chatelier, E., Yao, J., Wu, L., et al. (2014) · Nature · doi:10.1038/nature13568 · Cited by 2,177
Williams, C. D., Stengel, J., Asike, M. I., Torres, D. M., Shaw, J., Contreras, M., Landt, C. L., & Harrison, S. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.09.038 · Cited by 2,148
Vilstrup, H., Amodio, P., Bajaj, J., Cordoba, J., Ferenci, P., Mullen, K. D., Weissenborn, K., & Wong, P. (2014) · Hepatology · doi:10.1002/hep.27210 · Cited by 2,056
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.001 · Cited by 1,885
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765
Zhu, L., Baker, S. S., Gill, C., Liu, W., Alkhouri, R., Baker, R. D., & Gill, S. R. (2013) · Hepatology · doi:10.1002/hep.26093 · Cited by 1,708 · cited 1×
“coli, which is capable of producing ethanol under anaerobe conditions, it has been suggested that this rich gut microbiota may produce more ethanol than the microbiota of healthy individuals, as evidenced by the increased concentrations of intrinsically generated ethanol in the circulation as well as in the breath [33…”
BackgroundSamuel, B. S., Shaito, A., Motoike, T., Rey, F. E., Backhed, F., Manchester, J. K., Hammer, R. E., Williams, S. C., Crowley, J., Yanagisawa, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808567105 · Cited by 1,564
Boursier, J., Mueller, O., Barret, M., Machado, M., Fizanne, L., Araujo‐Perez, F., Guy, C. D., Seed, P. C., Rawls, J. F., David, L. A., et al. (2016) · Hepatology · doi:10.1002/hep.28356 · Cited by 1,483 · cited 1×
“, 2016 [56] Biopsy-proven NAFLD among 57 patients (France, USA) Fecal Microbiome: 16S rRNA gene Sequencing Patients with NASH and F2≥2: ↑ Bacteroides ↓ Prevotella.”
BackgroundCause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
Diehl, A. M., & Day, C. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1503519 · Cited by 1,283
Kozlitina, J., Smagris, E., Stender, S., Nordestgaard, B. G., Zhou, H. H., Tybjærg-Hansen, A., Vogt, T. F., Hobbs, H. H., & Cohen, J. C. (2014) · Nature Genetics · doi:10.1038/ng.2901 · Cited by 1,234
den Besten, G., Bleeker, A., Gerding, A., van Eunen, K., Havinga, R., van Dijk, T. H., Oosterveer, M. H., Jonker, J. W., Groen, A. K., Reijngoud, D.-J., et al. (2015) · Diabetes · doi:10.2337/db14-1213 · Cited by 1,125
Loomba, R., Seguritan, V., Li, W., Long, T., Klitgord, N., Bhatt, A., Dulai, P. S., Caussy, C., Bettencourt, R., Highlander, S. K., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.001 · Cited by 1,123
Gart, E., Souto Lima, E., Schuren, F., De Ruiter, C. G. F., Attema, J., Verschuren, L., Keijer, J., Salic, K., Morrison, M. C., & Kleemann, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010001 · Cited by 1,093
Dumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601056103 · Cited by 1,042
Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
Le Roy, T., Llopis, M., Lepage, P., Bruneau, A., Rabot, S., Bevilacqua, C., Martin, P., Philippe, C., Walker, F., Bado, A., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303816 · Cited by 1,001
Weight and Metabolic Outcomes 12 Years after Gastric Bypass
Adams, T. D., Davidson, L. E., Litwin, S. E., Kim, J., Kolotkin, R. L., Nanjee, M. N., Gutierrez, J. M., Frogley, S. J., Ibele, A. R., Brinton, E. A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1700459 · Cited by 956
Murphy, E. F., Cotter, P. D., Healy, S., Marques, T. M., O'Sullivan, O., Fouhy, F., Clarke, S. F., O'Toole, P. W., Quigley, E. M., Stanton, C., et al. (2010) · Gut · doi:10.1136/gut.2010.215665 · Cited by 946
Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease
Lebeaupin, C., Vallée, D., Hazari, Y., Hetz, C., Chevet, E., & Bailly-Maitre, B. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.008 · Cited by 944
Ye, Q., Zou, B., Yeo, Y. H., Li, J., Huang, D. Q., Wu, Y., Yang, H., Liu, C., Kam, L. Y., Tan, X. X. E., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30077-7 · Cited by 925
Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics
Lopez-Siles, M., Duncan, S. H., Garcia-Gil, L. J., & Martinez-Medina, M. (2017) · The ISME Journal · doi:10.1038/ismej.2016.176 · Cited by 874
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J. L., Diehl, A. M., Johnson, R. J., & Abdelmalek, M. F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.011 · Cited by 863
Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease
Duan, Y., Llorente, C., Lang, S., Brandl, K., Chu, H., Jiang, L., White, R. C., Clarke, T. H., Nguyen, K., Torralba, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1742-x · Cited by 844
Zhang, X., Coker, O. O., Chu, E. S., Fu, K., Lau, H. C. H., Wang, Y.-X., Chan, A. W. H., Wei, H., Yang, X., Sung, J. J. Y., et al. (2021) · Gut · doi:10.1136/gutjnl-2019-319664 · Cited by 841
Exercise alters gut microbiota composition and function in lean and obese humans
ALLEN, J. M., MAILING, L. J., NIEMIRO, G. M., MOORE, R., COOK, M. D., WHITE, B. A., HOLSCHER, H. D., & WOODS, J. A. (2018) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001495 · Cited by 820
Abdelmalek, M. F., Suzuki, A., Guy, C., Unalp-Arida, A., Colvin, R., Johnson, R. J., & Diehl, A. M. (2010) · Hepatology · doi:10.1002/hep.23535 · Cited by 770
Tremaroli, V., Karlsson, F., Werling, M., Ståhlman, M., Kovatcheva-Datchary, P., Olbers, T., Fändriks, L., le Roux, C. W., Nielsen, J., & Bäckhed, F. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.009 · Cited by 757
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
Perumpail, B. J., Khan, M. A., Yoo, E. R., Cholankeril, G., Kim, D., & Ahmed, A. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i47.8263 · Cited by 735
Inflammasome is a central player in the induction of obesity and insulin resistance
Stienstra, R., van Diepen, J. A., Tack, C. J., Zaki, M. H., van de Veerdonk, F. L., Perera, D., Neale, G. A., Hooiveld, G. J., Hijmans, A., Vroegrijk, I., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100255108 · Cited by 727
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
Hoyles, L., Fernández-Real, J.-M., Federici, M., Serino, M., Abbott, J., Charpentier, J., Heymes, C., Luque, J. L., Anthony, E., Barton, R. H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0061-3 · Cited by 720 · cited 1×
“, 2018 [59] Biopsy-proven NAFLD among 56 patients (UK, Italy, France) Fecal Microbiome: Shotgun Metagenomic Sequencing Serum and urine metabolites: LC/MS Among patients with steatosis: ↑ Proteobacteria ↑ Actinobacteria Among patients with steatosis: -Serum BCAAs: ↑ leucine ↑ valine ↑ isoleucine ↑ phenylacetic acid -Ur…”
BackgroundARAYA, J., RODRIGO, R., VIDELA, L. A., THIELEMANN, L., ORELLANA, M., PETTINELLI, P., & PONIACHIK, J. (2004) · Clinical Science · doi:10.1042/cs20030326 · Cited by 700
Del Chierico, F., Nobili, V., Vernocchi, P., Russo, A., De Stefanis, C., Gnani, D., Furlanello, C., Zandonà, A., Paci, P., Capuani, G., et al. (2017) · Hepatology · doi:10.1002/hep.28572 · Cited by 696 · cited 2×
“, 2017 [36] NAFLD in 61 patients and 51 non-NAFLD controls (Italy) Fecal Microbiome: rRNA Sequencing Serum metabolites: GC/MS Patients with NAFLD: ↑ Actinobacteria ↓ Bacteroidetes ↑ Ruminococcus ↑ Blautia ↑ Dorea ↓ Oscillospira ↓ Rikenellaceae Patients with NAFLD: ↑ 2-butanone ↑ 1-pentanol ↑ 4-methyl-2-pentanone”
BackgroundRivera, C. A., Adegboyega, P., van Rooijen, N., Tagalicud, A., Allman, M., & Wallace, M. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.019 · Cited by 693
The contribution of the large intestine to energy supplies in man
N I, M. (1984) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/39.2.338 · Cited by 691 · cited 1×
“SCFAs, mainly acetate, propionate, and butyrate are organic fatty acids synthesized from non-digestible proteins and fibers via anaerobic fermentation by the gut microbiota [66,67].”
BackgroundMancina, R. M., Dongiovanni, P., Petta, S., Pingitore, P., Meroni, M., Rametta, R., Borén, J., Montalcini, T., Pujia, A., Wiklund, O., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.032 · Cited by 676
Obesity, Diabetes, and Gut Microbiota
Musso, G., Gambino, R., & Cassader, M. (2010) · Diabetes Care · doi:10.2337/dc10-0556 · Cited by 665
Exercise Modifies the Gut Microbiota with Positive Health Effects
Monda, V., Villano, I., Messina, A., Valenzano, A., Esposito, T., Moscatelli, F., Viggiano, A., Cibelli, G., Chieffi, S., Monda, M., et al. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3831972 · Cited by 654
Jiang, W., Wu, N., Wang, X., Chi, Y., Zhang, Y., Qiu, X., Hu, Y., Li, J., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep08096 · Cited by 649
Barton, W., Penney, N. C., Cronin, O., Garcia-Perez, I., Molloy, M. G., Holmes, E., Shanahan, F., Cotter, P. D., & O'Sullivan, O. (2018) · Gut · doi:10.1136/gutjnl-2016-313627 · Cited by 647
Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
Arab, J. P., Karpen, S. J., Dawson, P. A., Arrese, M., & Trauner, M. (2017) · Hepatology · doi:10.1002/hep.28709 · Cited by 634
Bajaj, J. S., Kassam, Z., Fagan, A., Gavis, E. A., Liu, E., Cox, I. J., Kheradman, R., Heuman, D., Wang, J., Gurry, T., et al. (2017) · Hepatology · doi:10.1002/hep.29306 · Cited by 633
Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease
Begriche, K., Massart, J., Robin, M.-A., Bonnet, F., & Fromenty, B. (2013) · Hepatology · doi:10.1002/hep.26226 · Cited by 628
Waldecker, M., Kautenburger, T., Daumann, H., Busch, C., & Schrenk, D. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.08.002 · Cited by 615
Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids
den Besten, G., Lange, K., Havinga, R., van Dijk, T. H., Gerding, A., van Eunen, K., Müller, M., Groen, A. K., Hooiveld, G. J., Bakker, B. M., et al. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00265.2013 · Cited by 605
Intestinal transport and metabolism of bile acids
Dawson, P. A., & Karpen, S. J. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r054114 · Cited by 598 · cited 1×
“In the gut, BAs are implicated in the absorption of dietary fat, cholesterol, and fat-soluble vitamins [97,98].”
BackgroundBile Acids Activated Receptors Regulate Innate Immunity
Fiorucci, S., Biagioli, M., Zampella, A., & Distrutti, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01853 · Cited by 562
Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate
Zhao, S., Jang, C., Liu, J., Uehara, K., Gilbert, M., Izzo, L., Zeng, X., Trefely, S., Fernandez, S., Carrer, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2101-7 · Cited by 553
Zelber-Sagi, S., Nitzan-Kaluski, D., Goldsmith, R., Webb, M., Blendis, L., Halpern, Z., & Oren, R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.06.020 · Cited by 551
Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella Pneumoniae
Yuan, J., Chen, C., Cui, J., Lu, J., Yan, C., Wei, X., Zhao, X., Li, N., Li, S., Xue, G., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.018 · Cited by 548
Durable coexistence of donor and recipient strains after fecal microbiota transplantation
Li, S. S., Zhu, A., Benes, V., Costea, P. I., Hercog, R., Hildebrand, F., Huerta-Cepas, J., Nieuwdorp, M., Salojärvi, J., Voigt, A. Y., et al. (2016) · Science · doi:10.1126/science.aad8852 · Cited by 547
Mailing, L. J., Allen, J. M., Buford, T. W., Fields, C. J., & Woods, J. A. (2019) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000183 · Cited by 521
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review
Hashida, R., Kawaguchi, T., Bekki, M., Omoto, M., Matsuse, H., Nago, T., Takano, Y., Ueno, T., Koga, H., George, J., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.023 · Cited by 509
Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9
Garcia-Martinez, I., Santoro, N., Chen, Y., Hoque, R., Ouyang, X., Caprio, S., Shlomchik, M. J., Coffman, R. L., Candia, A., & Mehal, W. Z. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83885 · Cited by 498 · cited 1×
“For example, rodents deficient in TLR4 and myeloid-differentiation factor-2 (MD2) are protected from methionine- and choline-deficient diet-induced liver inflammation and liver steatosis [93].”
BackgroundGe, H., Li, X., Weiszmann, J., Wang, P., Baribault, H., Chen, J.-L., Tian, H., & Li, Y. (2008) · Endocrinology · doi:10.1210/en.2008-0059 · Cited by 475
Alisi, A., Bedogni, G., Baviera, G., Giorgio, V., Porro, E., Paris, C., Giammaria, P., Reali, L., Anania, F., & Nobili, V. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12758 · Cited by 471
Anthony, P. P., Ishak, K. G., Nayak, N. C., Poulsen, H. E., Scheuer, P. J., & Sobin, L. H. (1978) · Journal of Clinical Pathology · doi:10.1136/jcp.31.5.395 · Cited by 465
Häussinger, D., Kircheis, G., Fischer, R., Schliess, F., & Dahl, S. V. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80110-5 · Cited by 453
Beneficial Effects of a Probiotic VSL#3 on Parameters of Liver Dysfunction in Chronic Liver Diseases
Loguercio, C., Federico, A., Tuccillo, C., Terracciano, F., D'Auria, M. V., De Simone, C., & Blanco, C. D. V. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000165671.25272.0f · Cited by 449
Role of bile acids in metabolic control
Molinaro, A., Wahlström, A., & Marschall, H.-U. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.11.002 · Cited by 447
Pessayre, D., & Fromenty, B. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.004 · Cited by 441
Puri, P., Daita, K., Joyce, A., Mirshahi, F., Santhekadur, P. K., Cazanave, S., Luketic, V. A., Siddiqui, M. S., Boyett, S., Min, H., et al. (2018) · Hepatology · doi:10.1002/hep.29359 · Cited by 426 · cited 1×
“, 2018 [58] Biopsy-proven NAFLD among 86 patients and 24 non-NAFLD controls (USA) Serum metabolites: LC/MS No bacteria were further detected Patients with NAFLD and ≥F2: ↑ conjugated cholate ↓ ratio of total secondary to primary BAs Patients with NASH had ↑↑ total conjugated primary BAs when compared to controls”
BackgroundZhou, D., Pan, Q., Shen, F., Cao, H.-X., Ding, W.-J., Chen, Y.-W., & Fan, J.-G. (2017) · Scientific Reports · doi:10.1038/s41598-017-01751-y · Cited by 421
Expression and function of the bile acid receptor TGR5 in Kupffer cells
Keitel, V., Donner, M., Winandy, S., Kubitz, R., & Häussinger, D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.171 · Cited by 418
Svegliati‐Baroni, G., Saccomanno, S., Rychlicki, C., Agostinelli, L., De Minicis, S., Candelaresi, C., Faraci, G., Pacetti, D., Vivarelli, M., Nicolini, D., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02462.x · Cited by 405
Lee, G., You, H. J., Bajaj, J. S., Joo, S. K., Yu, J., Park, S., Kang, H., Park, J. H., Kim, J. H., Lee, D. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18754-5 · Cited by 395 · cited 1×
“, 2020 [62] Biopsy-proven NAFLD among 171 patients and 31 non-NAFLD controls (USA, Korea) Fecal Microbiome: 16S rRNA Sequencing Patients with NAFLD and >F2, non-obese: ↑ Ruminococcaceae ↑ Veillonellaceae Patients with NAFLD and >F2, non-obese: ↑ BA ↑ Propionate in feces”
BackgroundElevated endotoxin levels in non-alcoholic fatty liver disease
Harte, A. L., da Silva, N. F., Creely, S. J., McGee, K. C., Billyard, T., Youssef-Elabd, E. M., Tripathi, G., Ashour, E., Abdalla, M. S., Sharada, H. M., et al. (2010) · Journal of Inflammation · doi:10.1186/1476-9255-7-15 · Cited by 390
Chen, Y.-M., Liu, Y., Zhou, R.-F., Chen, X.-L., Wang, C., Tan, X.-Y., Wang, L.-J., Zheng, R.-D., Zhang, H.-W., Ling, W.-H., et al. (2016) · Scientific Reports · doi:10.1038/srep19076 · Cited by 358
Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis
Ma, Y.-Y. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i40.6911 · Cited by 352
Philips, C. A., Pande, A., Shasthry, S. M., Jamwal, K. D., Khillan, V., Chandel, S. S., Kumar, G., Sharma, M. K., Maiwall, R., Jindal, A., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.10.029 · Cited by 349
Experimental Endotoxemia Induces Adipose Inflammation and Insulin Resistance in Humans
Mehta, N. N., McGillicuddy, F. C., Anderson, P. D., Hinkle, C. C., Shah, R., Pruscino, L., Tabita-Martinez, J., Sellers, K. F., Rickels, M. R., & Reilly, M. P. (2010) · Diabetes · doi:10.2337/db09-0367 · Cited by 348
Reijnders, D., Goossens, G. H., Hermes, G. D. A., Neis, E. P. J. G., van der Beek, C. M., Most, J., Holst, J. J., Lenaerts, K., Kootte, R. S., Nieuwdorp, M., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.016 · Cited by 348
Rao, R. K., Seth, A., & Sheth, P. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00006.2004 · Cited by 340
A Gut Microbiome Signature for Cirrhosis Due to Nonalcoholic Fatty Liver Disease
Caussy, C., Tripathi, A., Humphrey, G., Bassirian, S., Singh, S., Faulkner, C., Bettencourt, R., Rizo, E., Richards, L., Xu, Z. Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09455-9 · Cited by 338
Rodrigo, R., Cauli, O., Gomez–Pinedo, U., Agusti, A., Hernandez–Rabaza, V., Garcia–Verdugo, J., & Felipo, V. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.040 · Cited by 338
Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
Ferslew, B. C., Xie, G., Johnston, C. K., Su, M., Stewart, P. W., Jia, W., Brouwer, K. L. R., & Sidney Barritt, A. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3776-8 · Cited by 335
Rahman, K., Desai, C., Iyer, S. S., Thorn, N. E., Kumar, P., Liu, Y., Smith, T., Neish, A. S., Li, H., Tan, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.022 · Cited by 334
Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States
Welzel, T. M., Graubard, B. I., Quraishi, S., Zeuzem, S., Davila, J. A., El-Serag, H. B., & McGlynn, K. A. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.160 · Cited by 328
Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy
Bajaj, J. S., Betrapally, N. S., Hylemon, P. B., Heuman, D. M., Daita, K., White, M. B., Unser, A., Thacker, L. R., Sanyal, A. J., Kang, D. J., et al. (2015) · Hepatology · doi:10.1002/hep.27819 · Cited by 325
Tilg, H., Moschen, A. R., & Szabo, G. (2016) · Hepatology · doi:10.1002/hep.28456 · Cited by 319
Vallianou, N., Stratigou, T., Christodoulatos, G. S., & Dalamaga, M. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00352-2 · Cited by 316
Self-citationChalasani, N., Guo, X., Loomba, R., Goodarzi, M. O., Haritunians, T., Kwon, S., Cui, J., Taylor, K. D., Wilson, L., Cummings, O. W., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.057 · Cited by 315
Molloy, J. W., Calcagno, C. J., Williams, C. D., Jones, F. J., Torres, D. M., & Harrison, S. A. (2012) · Hepatology · doi:10.1002/hep.24731 · Cited by 315
Palleja, A., Kashani, A., Allin, K. H., Nielsen, T., Zhang, C., Li, Y., Brach, T., Liang, S., Feng, Q., Jørgensen, N. B., et al. (2016) · Genome Medicine · doi:10.1186/s13073-016-0312-1 · Cited by 315
Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy
Sinha, R. A., You, S.-H., Zhou, J., Siddique, M. M., Bay, B.-H., Zhu, X., Privalsky, M. L., Cheng, S.-Y., Stevens, R. D., Summers, S. A., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60580 · Cited by 303 · cited 1×
“In fact, SCFAs are responsible for about 5–10% of the typical energy demands under normal conditions [70,71].”
BackgroundAkkermansia muciniphila improves metabolic profiles by reducing inflammation in chow diet-fed mice
Zhao, S., Liu, W., Wang, J., Shi, J., Sun, Y., Wang, W., Ning, G., Liu, R., & Hong, J. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0054 · Cited by 298
Jakobsdottir, G., Xu, J., Molin, G., Ahrné, S., & Nyman, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080476 · Cited by 297
Savard, C., Tartaglione, E. V., Kuver, R., Haigh, G. W., Farrell, G. C., Subramanian, S., Chait, A., Yeh, M. M., Quinn, L. S., & Ioannou, G. N. (2013) · Hepatology · doi:10.1002/hep.25789 · Cited by 295
Bajaj, J. S., Salzman, N. H., Acharya, C., Sterling, R. K., White, M. B., Gavis, E. A., Fagan, A., Hayward, M., Holtz, M. L., Matherly, S., et al. (2019) · Hepatology · doi:10.1002/hep.30690 · Cited by 295
Munukka, E., Rintala, A., Toivonen, R., Nylund, M., Yang, B., Takanen, A., Hänninen, A., Vuopio, J., Huovinen, P., Jalkanen, S., et al. (2017) · The ISME Journal · doi:10.1038/ismej.2017.24 · Cited by 278
Llorente, C., Jepsen, P., Inamine, T., Wang, L., Bluemel, S., Wang, H. J., Loomba, R., Bajaj, J. S., Schubert, M. L., Sikaroodi, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00796-x · Cited by 257 · cited 2×
“, 2017 [46] Sublytic Atp4aSl/Sl mice treated with PPIs ↑ Enterococcus faecalis with PPIs Figure 2.”
BackgroundAstrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy
Kimelberg, H. K. (2005) · Glia · doi:10.1002/glia.20174 · Cited by 257
Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome
Barrea, L., Annunziata, G., Muscogiuri, G., Di Somma, C., Laudisio, D., Maisto, M., De Alteriis, G., Tenore, G. C., Colao, A., & Savastano, S. (2018) · Nutrients · doi:10.3390/nu10121971 · Cited by 257
How different is the dietary pattern in non-alcoholic steatohepatitis patients?
Cortez-Pinto, H., Jesus, L., Barros, H., Lopes, C., Moura, M. C., & Camilo, M. E. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.01.027 · Cited by 247
Lenoir, M., Martín, R., Torres-Maravilla, E., Chadi, S., González-Dávila, P., Sokol, H., Langella, P., Chain, F., & Bermúdez-Humarán, L. G. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1826748 · Cited by 245
Vallianou, N., Stratigou, T., Christodoulatos, G. S., Tsigalou, C., & Dalamaga, M. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00379-w · Cited by 242
Self-citationNon-alcoholic fatty liver and the gut microbiota
Bashiardes, S., Shapiro, H., Rozin, S., Shibolet, O., & Elinav, E. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.003 · Cited by 241
Effect of rectal infusion of short chain fatty acids in human subjects.
Tm, W., Brighenti, F., Royall, D., Al, J., & Dj, J. (1989) · PubMed · Cited by 240
Munukka, E., Ahtiainen, J. P., Puigbó, P., Jalkanen, S., Pahkala, K., Keskitalo, A., Kujala, U. M., Pietilä, S., Hollmén, M., Elo, L., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02323 · Cited by 237
Fructose as a key player in the development of fatty liver disease
Basaranoglu, M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i8.1166 · Cited by 235
Trépo, E., Nahon, P., Bontempi, G., Valenti, L., Falleti, E., Nischalke, H.-D., Hamza, S., Corradini, S. G., Burza, M. A., Guyot, E., et al. (2014) · Hepatology · doi:10.1002/hep.26767 · Cited by 233
Vitaglione, P., Morisco, F., Mazzone, G., Amoruso, D. C., Ribecco, M. T., Romano, A., Fogliano, V., Caporaso, N., & D'Argenio, G. (2010) · Hepatology · doi:10.1002/hep.23902 · Cited by 232
Csak, T., Velayudham, A., Hritz, I., Petrasek, J., Levin, I., Lippai, D., Catalano, D., Mandrekar, P., Dolganiuc, A., Kurt-Jones, E., et al. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00163.2009 · Cited by 229
Nair, S. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02265-1 · Cited by 212
Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia
Bauer, T. M., Schwacha, H., Steinbruckner, B., Brinkmann, F. E., Ditzen, A. K., Aponte, J. J., Pelz, K., Berger, D., Kist, M., & Blum, H. E. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05791.x · Cited by 211
Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease
Paolella, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15518 · Cited by 211
Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis
Ahluwalia, V., Betrapally, N. S., Hylemon, P. B., White, M. B., Gillevet, P. M., Unser, A. B., Fagan, A., Daita, K., Heuman, D. M., Zhou, H., et al. (2016) · Scientific Reports · doi:10.1038/srep26800 · Cited by 211
Govender, M., Choonara, Y. E., Kumar, P., du Toit, L. C., van Vuuren, S., & Pillay, V. (2013) · AAPS PharmSciTech · doi:10.1208/s12249-013-0027-1 · Cited by 210
Urea cycle dysregulation in non-alcoholic fatty liver disease
De Chiara, F., Heebøll, S., Marrone, G., Montoliu, C., Hamilton-Dutoit, S., Ferrandez, A., Andreola, F., Rombouts, K., Grønbæk, H., Felipo, V., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.023 · Cited by 208
Caussy, C., Hsu, C., Lo, M., Liu, A., Bettencourt, R., Ajmera, V. H., Bassirian, S., Hooker, J., Sy, E., Richards, L., et al. (2018) · Hepatology · doi:10.1002/hep.29892 · Cited by 205 · cited 1×
“, 2018 [60] Discovery cohort of 156 twins Validation cohort of Biopsy-proven NAFLD among 156 patients (USA, France) Fecal Microbiome: Whole Shotgun Metagenomics Sequencing Liver: MRI-PDFF; MRE Serum metabolites: LC/MS; GC/MS Patients with NAFLD and >F2: ↑ Furmicutes ↑ Bacteroidetes ↑ Proteobacteria 56 metabolites had…”
BackgroundEndotoxemia produces coma and brain swelling in bile duct ligated rats
Wright, G., Davies, N. A., Shawcross, D. L., Hodges, S. J., Zwingmann, C., Brooks, H. F., Mani, A. R., Harry, D., Stadlbauer, V., Zou, Z., et al. (2007) · Hepatology · doi:10.1002/hep.21599 · Cited by 199
Setiawan, V. W., Wilkens, L. R., Lu, S. C., Hernandez, B. Y., Le Marchand, L., & Henderson, B. E. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.10.005 · Cited by 189
The bile acid membrane receptor TGR5: a valuable metabolic target
Pols, T. W. H., Noriega, L. G., Nomura, M., Auwerx, J., & Schoonjans, K. (2011) · Digestive Diseases · doi:10.1159/000324126 · Cited by 185
Influence of Exercise on the Human Gut Microbiota of Healthy Adults: A Systematic Review
Ortiz-Alvarez, L., Xu, H., & Martínez‐Téllez, B. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000126 · Cited by 185
Microglia activation in hepatic encephalopathy in rats and humans
Zemtsova, I., Görg, B., Keitel, V., Bidmon, H.-J., Schrör, K., & Häussinger, D. (2011) · Hepatology · doi:10.1002/hep.24326 · Cited by 178
Carbajo-Pescador, S., Porras, D., García-Mediavilla, M. V., Martínez-Flórez, S., Juarez-Fernández, M., Cuevas, M. J., Mauriz, J. L., González-Gallego, J., Nistal, E., & Sánchez-Campos, S. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039206 · Cited by 178
Zhou, J., Farah, B. L., Sinha, R. A., Wu, Y., Singh, B. K., Bay, B.-H., Yang, C. S., & Yen, P. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087161 · Cited by 177
Singh, V., Chassaing, B., Zhang, L., San Yeoh, B., Xiao, X., Kumar, M., Baker, M. T., Cai, J., Walker, R., Borkowski, K., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.028 · Cited by 175
Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease
Minno, M. N. D. D. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i41.5839 · Cited by 174
The role of the gut microbiome in chronic liver disease: the clinical evidence revised
Schwenger, K. J., Clermont-Dejean, N., & Allard, J. P. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.04.004 · Cited by 171
Adaptations in gastrointestinal physiology after sleeve gastrectomy and Roux-en-Y gastric bypass
Steenackers, N., Vanuytsel, T., Augustijns, P., Tack, J. F., Mertens, A. C., Lannoo, M., der Schueren, B. V., & Matthys, C. (2021) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(20)30302-2 · Cited by 171
Yang, G., Lee, H. E., & Lee, J. Y. (2016) · Scientific Reports · doi:10.1038/srep24399 · Cited by 170
Jover, R., Rodrigo, R., Felipo, V., Insausti, R., Sáez‐Valero, J., García‐Ayllón, M. S., Suárez, I., Candela, A., Compañ, A., Esteban, A., et al. (2006) · Hepatology · doi:10.1002/hep.21180 · Cited by 167
Gangarapu, V., İnce, A. T., Baysal, B., Kayar, Y., Klç, U., Gök, Ö., Uysal, Ö., & Şentürk, H. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000348 · Cited by 164
Updates on Dietary Models of Nonalcoholic Fatty Liver Disease: Current Studies and Insights
Stephenson, K., Kennedy, L. L., Hargrove, L. A., Demieville, J., Thomson, J., Alpini, G. D., & Francis, H. (2017) · Gene Expression · doi:10.3727/105221617x15093707969658 · Cited by 164
Nimer, N. A., Choucair, I., Wang, Z., Nemet, I., Li, L., Gukasyan, J., Weeks, T. L., Alkhouri, N., Zein, N. N., Tang, W. H. W., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154457 · Cited by 164
Microbiome, trimethylamine N-oxide, and cardiometabolic disease
Tang, W. H. W., & Hazen, S. L. (2017) · Translational Research · doi:10.1016/j.trsl.2016.07.007 · Cited by 160
Xu, J., Lai, K. K. Y., Verlinsky, A., Lugea, A., French, S. W., Cooper, M. P., Ji, C., & Tsukamoto, H. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.034 · Cited by 159
Petta, S., Miele, L., Bugianesi, E., Cammà, C., Rosso, C., Boccia, S., Cabibi, D., Marco, V. D., Grimaudo, S., Grieco, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087523 · Cited by 158
Reduction in VLDL, but not HDL, in plasma of rats deficient in choline
Yao, Z., & Vance, D. E. (1990) · Biochemistry and Cell Biology · doi:10.1139/o90-079 · Cited by 156
Sakata, R., Nakamura, T., Torimura, T., Ueno, T., & Sata, M. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1503 · Cited by 149
Cholineʼs role in maintaining liver function: new evidence for epigenetic mechanisms
Mehedint, M. G., & Zeisel, S. H. (2013) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283600d46 · Cited by 148
Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
Lu, W., Li, S., Li, J., Wang, J., Zhang, R., Zhou, Y., Yin, Q., Zheng, Y., Wang, F., Xia, Y., et al. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/1459790 · Cited by 147
Richardson, A. J., McKain, N., & Wallace, R. J. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-6 · Cited by 143
Akkermansia muciniphila: a novel functional microbe with probiotic properties
Gómez-Gallego, C., Pohl, S., Salminen, S., de Vos, W. M., & Kneifel, W. (2016) · Beneficial Microbes · doi:10.3920/bm2016.0009 · Cited by 142
Editing the microbiome the CRISPR way
Ramachandran, G., & Bikard, D. (2019) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2018.0103 · Cited by 138
Synthesis of urea after stimulation with amino acids: relation to liver function.
Vilstrup, H. (1980) · Gut · doi:10.1136/gut.21.11.990 · Cited by 137
Balzano, T., Dadsetan, S., Forteza, J., Cabrera‐Pastor, A., Taoro‐González, L., Malaguarnera, M., Gil‐Perotín, S., Cubas-Núñez, L., Casanova, B., Castro-Quintas, Á., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.01.008 · Cited by 137
Cowan, T. E., Palmnäs, M. S. A., Yang, J., Bomhof, M. R., Ardell, K. L., Reimer, R. A., Vogel, H. J., & Shearer, J. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.12.009 · Cited by 134
Systematic review with meta‐analysis: coffee consumption and the risk of cirrhosis
Kennedy, O. J., Roderick, P. J., Buchanan, R. M., Fallowfield, J. A., Hayes, P. C., & Parkes, J. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13523 · Cited by 134
Juanola, O., Ferrusquía‐Acosta, J., García-Villalba, R., Zapater, P., Magaz, M., Marín, A., Olivas, P., Baiges, A., Bellot, P., Turón, F., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901327r · Cited by 132
Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma
Gerbes, A. L., Zoulim, F., Tilg, H., Dufour, J., Bruix, J., Paradis, V., Salem, R., Peck‐Radosavljevic, M., Galle, P. R., Greten, T. F., et al. (2017) · Gut · doi:10.1136/gutjnl-2017-315068 · Cited by 131
Shavakhi, A., Minakari, M., Firouzian, H., Assali, R., Hekmatdoost, A., & Ferns, G. A. (2013) · PubMed Central · Cited by 123
Falleti, E., Fabris, C., Cmet, S., Cussigh, A., Bitetto, D., Fontanini, E., Fornasiere, E., Bignulin, S., Fumolo, E., Bignulin, E., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02534.x · Cited by 123
Seo, D.-B., Jeong, H. W., Cho, D., Lee, B. J., Lee, J. H., Choi, J. Y., Bae, I., & Lee, S. (2015) · Journal of Medicinal Food · doi:10.1089/jmf.2014.3265 · Cited by 122
Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes
León‐Mimila, P., Villamil‐Ramírez, H., Li, X. S., Shih, D. M., Hui, S. T. Y., Ocampo‐Medina, E., López-Contreras, B. E., Morán‐Ramos, S., Olivares-Arévalo, M., Grandini-Rosales, P., et al. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.07.010 · Cited by 119
Askari, G., Pezeshki, A., Safi, S., Feizi, A., & Karami, F. (2016) · International Journal of Preventive Medicine · doi:10.4103/2008-7802.173051 · Cited by 116
Comparison of diet versus exercise on metabolic function and gut microbiota in obese rats
WELLY, R. J., LIU, T.-W., ZIDON, T. M., ROWLES, J. L., PARK, Y.-M., SMITH, T. N., SWANSON, K. S., PADILLA, J., & VIEIRA-POTTER, V. J. (2016) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000964 · Cited by 114
Vallianou, N. G., Dalamaga, Μ., Stratigou, T., Karampela, Ι., & Tsigalou, C. (2021) · Current Obesity Reports · doi:10.1007/s13679-021-00438-w · Cited by 112
Self-citationAmmonia Scavenging Prevents Progression of Fibrosis in Experimental Nonalcoholic Fatty Liver Disease
Chiara, F. D., Thomsen, K. L., Habtesion, A., Jones, H., Davies, N. A., Gracia‐Sancho, J., Manicardi, N., Hall, A. R., Andreola, F., Paish, H. L., et al. (2019) · Hepatology · doi:10.1002/hep.30890 · Cited by 110
Cagnin, A., Taylor-Robinson, S. D., Forton, D. M., & Banati, R. B. (2005) · Gut · doi:10.1136/gut.2005.075051 · Cited by 109
Zhang, M., Zhou, L., Wang, Y., Dorfman, R. G., Tang, D., Xu, L., Pan, Y., Zhou, Q., Li, Y., Yin, Y., et al. (2019) · International Immunology · doi:10.1093/intimm/dxz022 · Cited by 107
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
Wong, C. R., Nguyen, M. H., & Lim, J. K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i37.8294 · Cited by 106
Arulanandan, A., Ang, B., Bettencourt, R., Hooker, J. C., Behling, C. A., Lin, G., Valasek, M. A., Ix, J. H., Schnabl, B., Sirlin, C. B., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.01.027 · Cited by 105
Lau, L. H. S., & Wong, S. H. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-8684-7_9 · Cited by 104
Dietary butyrate suppresses inflammation through modulating gut microbiota in high-fat diet-fed mice
Zhai, S., Qin, S., Li, L., Zhu, L., Zou, Z., & Wang, L. (2019) · FEMS Microbiology Letters · doi:10.1093/femsle/fnz153 · Cited by 101
Improvement of non‐invasive markers of NAFLD from an individualised, web‐based exercise program
Huber, Y., Pfirrmann, D., Gebhardt, I., Labenz, C., Gehrke, N., Straub, B. K., Ruckes, C., Bantel, H., Belda, E., Clément, K., et al. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15427 · Cited by 101
Personalizing Breast Cancer Staging by the Inclusion of ER, PR, and HER2
Bagaria, S. P., Ray, P., Sim, M., Ye, X., Shamonki, J. M., Cui, X., & Giuliano, A. E. (2013) · JAMA Surgery · doi:10.1001/jamasurg.2013.3181 · Cited by 100
Gao, X., Zhu, Y., Yang, W., Liu, G., & Wan, C. (2016) · Hepatology Research · doi:10.1111/hepr.12671 · Cited by 99
Nakayama, T., & Oishi, K. (2013) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12142 · Cited by 97
Gut Microbiota in Obesity and Metabolic Abnormalities: A Matter of Composition or Functionality?
Morán‐Ramos, S., López-Contreras, B. E., & Canizales‐Quinteros, S. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.11.003 · Cited by 96
Santamarina, A. B., Carvalho‐Silva, M., Gomes, L. M., Okuda, M. H., de Santana, A. A., STRECK, E. L., Seelaender, M. C. L., do Nascimento, C. M. O., Ribeiro, E. B., Lira, F. S., et al. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.07.002 · Cited by 95
Abdelmalek, M. F., Liu, C., Shuster, J. J., Nelson, D. R., & Asal, N. R. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.06.001 · Cited by 94
Masarone, M., Troisi, J., Aglitti, A., Torre, P., Colucci, A., Dallio, M., Federico, A., Balsano, C., & Persico, M. (2021) · Metabolomics · doi:10.1007/s11306-020-01756-1 · Cited by 93
Høier, B., Rufener, N., Bojsen‐Møller, J., Bangsbo, J., & Hellsten, Y. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.190439 · Cited by 92
Bile acid receptors and nonalcoholic fatty liver disease
Yuan, L., & Bambha, K. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i28.2811 · Cited by 89
Stenman, L. K., Burcelin, R., & Lahtinen, S. J. (2015) · Beneficial Microbes · doi:10.3920/bm2015.0069 · Cited by 87
Chen, M., Hui, S., Lang, H., Zhou, M., Zhang, Y., Kang, C., Zeng, X., Zhang, Q., Yi, L., & Mi, M. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800612 · Cited by 87
Belgaumkar, A. P., Vincent, R. P., Carswell, K. A., Hughes, R. D., Alaghband-Zadeh, J., Mitry, R. R., le Roux, C. W., & Patel, A. G. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1878-1 · Cited by 83
Pierantonelli, I., Rychlicki, C., Agostinelli, L., Giordano, D. M., Gaggini, M., Fraumene, C., Saponaro, C., Manghina, V., Sartini, L., Mingarelli, E., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11744-6 · Cited by 82 · cited 2×
“, 2017 [45] NLRP3 Knockout mice ↓ Gram negative species ↓ Bacterial translocation after treatment with antibiotics”
BackgroundAdams, L. A., Wang, Z., Liddle, C., Melton, P. E., Ariff, A., Chandraratna, H. S., Tan, J. T. H., Ching, H. L., Coulter, S., de Boer, B., et al. (2020) · Liver International · doi:10.1111/liv.14453 · Cited by 82
Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion
Eriksen, P. L., Vilstrup, H., Rigbolt, K., Suppli, M. P., Sørensen, M., Heebøll, S., Veidal, S. S., Knop, F. K., & Thomsen, K. L. (2019) · Liver International · doi:10.1111/liv.14205 · Cited by 81
Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease
Leung, C., Herath, C. B., Jia, Z., Andrikopoulos, S., Brown, B. E., Davies, M. J., Rivera, L. R., Furness, J. B., Forbes, J. M., & Angus, P. W. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i35.8026 · Cited by 80
Ammonia and inflammation in the pathogenesis of hepatic encephalopathy
Wright, G. A. K., & Jalan, R. (2007) · Hepatology · doi:10.1002/hep.21843 · Cited by 73
The interplay of obesity, gut microbiome and diet in the immune check point inhibitors therapy era
Spyrou, N., Vallianou, N. G., Kadillari, J., & Dalamaga, Μ. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.008 · Cited by 72
Self-citationThomsen, K. L., Grønbæk, H., Glavind, E., Hebbard, L., Jessen, N., Clouston, A. D., George, J., & Vilstrup, H. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00036.2014 · Cited by 70
Kelly, C. R., Kim, A. M., Laine, L., & Wu, G. D. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.028 · Cited by 70
Baker, C. J., Martinez‐Huenchullan, S. F., D'Souza, M., Xu, Y., Li, M., Bi, Y., Johnson, N. A., & Twigg, S. M. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13086 · Cited by 69
Farin, W., Oñate, F. P., Plassais, J., Bonny, C., Beglinger, C., Woelnerhanssen, B., Nocca, D., Magoulès, F., Chatelier, E. L., Pons, N., et al. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.03.014 · Cited by 69
Higarza, S. G., Arboleya, S., Gueimonde, M., Gómez-Lázaro, E., Arias, J. L., & Arias, N. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223019 · Cited by 67
Hamurcu, P., Kaya, E., Alphan, E., & Yilmaz, Y. N. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001656 · Cited by 65
Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis
Schneider, K. M., Mohs, A., Kilic, K., Candels, L. S., Elfers, C., Bennek, E., Schneider, L. B., Heymann, F., Gaßler, N., Penders, J., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020308 · Cited by 63
Loomba, R. S., Hwang, S., O’Donnell, C. J., Ellison, R. C., Vasan, R. S., D’Agostino, R. B., Liang, T. J., & Fox, C. S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.037 · Cited by 62
Cited by
Mostafavi Abdolmaleky, H., & Zhou, J.-R. (2024) · Antioxidants · doi:10.3390/antiox13080985 · Cited by 286
Buchynskyi, M., Kamyshna, I., Halabitska, I., Petakh, P., Kunduzova, O., Oksenych, V., & Kamyshnyi, O. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1577724 · Cited by 30
Metadata
- Authors
- Vallianou, N., Christodoulatos, G. S., Karampela, I., Tsilingiris, D., Magkos, F., Stratigou, T., Kounatidis, D., & Dalamaga, M.
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2021-12-31
- Volume
- 12
- Issue
- 1
- Pages
- 56
- ISSN
- 2218-273X (ISSN-L)
- OpenAlex
- W4205859368
- Cited by
- 289
- References
- 229
- FWCI
- 10.47
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.